Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms26010231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Bingqi Zhuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China. Hauptthemen laut MEDLINE: Myocardial Infarction, RNA, Untranslated, Stem Cell Transplantation, Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Myocardial infarction (MI) is a highly challenging and fatal disease, with diverse challenges arising at different stages of its progression. As such, non-coding RNAs (ncRNAs), which can broadly regulate cell fate, and stem cells with multi-differentiation potential are emerging as novel therapeutic approaches for treating MI across its various stages. NcRNAs, including microRNAs (miRNAs) and long non-coding RNAs (LncRNAs), can directly participate in regulating intracellular signaling pathways, influence cardiac angiogenesis, and promote the repair of infarcted myocardium. Currently, stem cells commonly used in medicine, such as mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs), can differentiate into various human cell types without ethical concerns. When combined with ncRNAs, these stem cells can more effectively induce directed differentiation, promote angiogenesis in the infarcted heart, and replenish normal cardiac cells. Additionally, stem cell-derived exosomes, which contain various ncRNAs, can improve myocardial damage in the infarcted region through paracrine mechanisms. However, our understanding of the specific roles and mechanisms of ncRNAs, stem cells, and exosomes secreted by stem cells during different stages of MI remains limited. Therefore, this review systematically categorizes the different stages of MI, aiming to summarize the direct regulatory effects of ncRNAs on an infarcted myocardium at different points of disease progression. Moreover, it explores the specific roles and mechanisms of stem cell therapy and exosome therapy in this complex pathological evolution process. The objective of this review was to provide novel insights into therapeutic strategies for different stages of MI and open new research directions for the application of stem cells and ncRNAs in the field of MI repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
- Experimental Teaching Center, College of Pharmacy, Yanbian University, Yanji 133002, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhuang, B., Zhong, C., Ma, Y., Wang, A., Quan, H., & Hong, L. (2024). Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010231
Vancouver
Zhuang B, Zhong C, Ma Y, Wang A, Quan H, Hong L. Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010231
BibTeX
@article{Zhuang2024,
author = {Zhuang, Bingqi and Zhong, Chongning and Ma, Yuting and Wang, Ao and Quan, Hailian and Hong, Lan},
title = {Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms26010231}
}
EUVIMED